Marcadores no invasivos de hígado graso no alcohólico y relación con parámetros de obesidad

  1. Mª Teófila Vicente-Herrero 1
  2. Mª Victoria Ramírez-Iñiguez de la Torre 2
  3. María Gordito Soler
  4. Ángel Arturo López-González 1
  1. 1 Grupo Obesidad y Trabajo-Asociación Española de Especialistas en Medicina del Trabajo-AEEMT (España).Grupo ADEMA-SALUD del Instituto Universitario de Ciencias de la Salud-IUNICS Illes Balears (España)
  2. 2 Grupo Correos-SEPI-Albacete y Cuenca. Grupo Obesidad y Trabajo- Asociación Española de Especialistas en Medicina del Trabajo-AEEMT (España)
Journal:
Academic Journal of Health Sciences: Medicina Balear

ISSN: 2255-0560

Year of publication: 2022

Volume: 37

Issue: 6

Pages: 21-26

Type: Article

DOI: 10.3306/AJHS.2022.37.06.21 DIALNET GOOGLE SCHOLAR lock_openIbdigital editor

Abstract

Introduction and objective: To analyze the usefulness of the FLI and FIB-4 predictive indexes in the detection of nonalcoholic fatty liver disease (NAFLD) as a noninvasive method in occupational health and its relationship with obesity and metabolic risk parameters.Material and method: Descriptive and cross-sectional study in 815 workers aged 18-65 years from March 2020-June 2021. We used FIB-4 Index for liver fibrosis and Fatty Liver Index (FLI) and established relationships with body mass index, and with adiposity indices: body fat, visceral fat, waist circumference, waist/hip ratio, waist/height ratio and metabolic syndrome.Results: High BMI values with differences by gender (overweight 48.5% in men and 39.52% in women) (obesity 22.04% in men and 18.86% in women), FLI shows altered values in men and women in all obesity parameters and with metabolic syndrome. FIB 4 shows differences by gender, in men with mean values related to visceral fat and high waist/height circumference and in women, in ranges unrelated to any of the parameters assessed.Conclusion: FLI shows a relationship with elevated BMI values and obesity parameters such as visceral fat and waist/hip ratio. FIB-4 only shows a relationship with visceral fat and BMI. Metabolic syndrome only correlates with mean FLI values.

Bibliographic References

  • Arroyo-Johnson C, Mincey KD. Obesity Epidemiology Worldwide. Gastroenterol Clin North Am. 2016 Dec;45(4):571-9.
  • Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019 Mar;92:6-10.
  • Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):637-53.
  • Ramai D, Facciorusso A, Vigandt E, Schaf B, Saadedeen W, Chauhan A, et al. Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. Cells. 2021 Dec 2;10(12):3401.
  • Organización Mundial de la Salud 2020. Body mass index – BMI. Disponible en: https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi (consultado 14/03/2022).
  • Taberner R. Calculadora multiplataforma para síndrome metabólico y riesgo cardiovascular en pacientes con psoriasis [Multiplatform application to determine presence of metabolic syndrome and cardiovascular risk in patients with psoriasis]. Actas Dermosifiliogr. 2012 Mar;103(2):111-9.
  • Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006 Nov 2;6:33.
  • Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. J Hepatol. 2018 Feb;68(2):305-15.
  • Cinza Sanjurjo S, Prieto Díaz MÁ, Llisterri Caro JL, Barquilla García A, Rodríguez Padial L, Vidal Pérez R, et al. Prevalencia de obesidad y comorbilidad cardiovascular asociada en los pacientes incluidos en el estudio IBERICAN (Identificación de la población Española de Riesgo Cardiovascular y renal). Semergen. 2019 Jul-Aug;45(5):311-22.
  • Gažarová M, Galšneiderová M, Mečiarová L. Obesity diagnosis and mortality risk based on a body shape index (ABSI) and other indices and anthropometric parameters in university students. Rocz Panstw Zakl Hig. 2019;70(3):267-75.
  • Fang H, Berg E, Cheng X, Shen W, et al. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018 Sep;21(5):360-5.
  • Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012 Mar;13(3):275-86.
  • Bedogni G, Kahn HS, Bellentani S, Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol. 2010 Aug 25;10:98.
  • Wada T, Zeniya M. Background of the FIB-4 index in Japanese non-alcoholic fatty liver disease. Intern Med. 2015;54(2):127-32.
  • Goldman O, Ben-Assuli O, Rogowski O, Zeltser D, Shapira I, Berliner S, et al. Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine. J Med Syst. 2021 Jan 11;45(2):22.
  • Petta S, Amato MC, Di Marco V, Cammà C, Pizzolanti G, Barcellona MR, et al. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012 Jan;35(2):238-47.
  • Narankiewicz D, Ruiz-Nava J, Buonaiuto V, Ruiz-Moreno MI, López-Carmona MD, Pérez-Belmonte LM, et al. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population. Int J Environ Res Public Health. 2020 May 18;17(10):3518.
  • Cheng YL, Wang YJ, Lan KH, Huo TI, Huang YH, Su CW, et al. Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease. Gastroenterol Res Pract. 2017;2017:9279836.
  • Eren F, Kaya E, Yilmaz Y. Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index: failure in the prediction of advanced fibrosis in lean and morbidly obese individuals. Eur J Gastroenterol Hepatol. 2022 Jan 1;34(1):98-103.
  • Jung CH, Rhee EJ, Kwon H, Chang Y, Ryu S, Lee WY. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis. Endocrinol Metab (Seoul). 2020 Mar;35(1):165-76.
  • Schreiner AD, Zhang J, Durkalski-Mauldin V, Livingston S, Marsden J, Bian J, et al. Advanced liver fibrosis and the metabolic syndrome in a primary care setting. Diabetes Metab Res Rev. 2021 Nov;37(8):e3452.
Data source: Dialnet